Research Article
Effect of Melatonin Administration on Mitochondrial Activity and Oxidative Stress Markers in Patients with Parkinson’s Disease
Figure 1
Plasma levels of oxidative stress markers at baseline and after 3 months of treatment in the placebo and melatonin groups. (a) Lipoperoxides ( hydroxyalkenes), (b) nitric oxide metabolites (nitrates and nitrites), (c) carbonyl groups in proteins, and (d) catalase enzyme activity. Data of the and a are shown.
(a) |
(b) |
(c) |
(d) |